Literature DB >> 27160901

Hippo Signaling Mediators Yap and Taz Are Required in the Epicardium for Coronary Vasculature Development.

Anamika Singh1, Sindhu Ramesh1, Dasan Mary Cibi1, Lim Sze Yun2, Jun Li3, Li Li3, Lauren J Manderfield3, Eric N Olson4, Jonathan A Epstein5, Manvendra K Singh6.   

Abstract

Formation of the coronary vasculature is a complex and precisely coordinated morphogenetic process that begins with the formation of epicardium. The epicardium gives rise to many components of the coronary vasculature, including fibroblasts, smooth muscle cells, and endothelium. Hippo signaling components have been implicated in cardiac development and regeneration. However, a role of Hippo signaling in the epicardium has not been explored. Employing a combination of genetic and pharmacological approaches, we demonstrate that inhibition of Hippo signaling mediators Yap and Taz leads to impaired epicardial epithelial-to-mesenchymal transition (EMT) and a reduction in epicardial cell proliferation and differentiation into coronary endothelial cells. We provide evidence that Yap and Taz control epicardial cell behavior, in part by regulating Tbx18 and Wt1 expression. Our findings show a role for Hippo signaling in epicardial cell proliferation, EMT, and cell fate specification during cardiac organogenesis.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippo signaling; Taz; Yap; epicardium; epithelial to mesenchymal transition (EMT); proepicardium

Mesh:

Substances:

Year:  2016        PMID: 27160901      PMCID: PMC4871746          DOI: 10.1016/j.celrep.2016.04.027

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  42 in total

1.  Epicardium-derived cardiac mesenchymal stem cells: expanding the outer limit of heart repair.

Authors:  Manvendra K Singh; Jonathan A Epstein
Journal:  Circ Res       Date:  2012-03-30       Impact factor: 17.367

2.  A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.

Authors:  Masao Murakami; Masayo Nakagawa; Eric N Olson; Osamu Nakagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

3.  The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass.

Authors:  Noriyuki Nishioka; Ken-ichi Inoue; Kenjiro Adachi; Hiroshi Kiyonari; Mitsunori Ota; Amy Ralston; Norikazu Yabuta; Shino Hirahara; Robert O Stephenson; Narumi Ogonuki; Ryosuke Makita; Hiroki Kurihara; Elizabeth M Morin-Kensicki; Hiroshi Nojima; Janet Rossant; Kazuki Nakao; Hitoshi Niwa; Hiroshi Sasaki
Journal:  Dev Cell       Date:  2009-03       Impact factor: 12.270

4.  Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin.

Authors:  Ofelia M Martínez-Estrada; Laura A Lettice; Abdelkader Essafi; Juan Antonio Guadix; Joan Slight; Víctor Velecela; Emma Hall; Judith Reichmann; Paul S Devenney; Peter Hohenstein; Naoki Hosen; Robert E Hill; Ramón Muñoz-Chapuli; Nicholas D Hastie
Journal:  Nat Genet       Date:  2009-12-20       Impact factor: 38.330

5.  Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells.

Authors:  Tamar C Katz; Manvendra K Singh; Karl Degenhardt; José Rivera-Feliciano; Randy L Johnson; Jonathan A Epstein; Clifford J Tabin
Journal:  Dev Cell       Date:  2012-03-13       Impact factor: 12.270

6.  Hippo pathway activity influences liver cell fate.

Authors:  Dean Yimlamai; Constantina Christodoulou; Giorgio G Galli; Kilangsungla Yanger; Brian Pepe-Mooney; Basanta Gurung; Kriti Shrestha; Patrick Cahan; Ben Z Stanger; Fernando D Camargo
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

7.  Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65.

Authors:  Elizabeth M Morin-Kensicki; Brian N Boone; Michael Howell; Jaclyn R Stonebraker; Jeremy Teed; James G Alb; Terry R Magnuson; Wanda O'Neal; Sharon L Milgram
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

8.  Adult mouse epicardium modulates myocardial injury by secreting paracrine factors.

Authors:  Bin Zhou; Leah B Honor; Huamei He; Qing Ma; Jin-Hee Oh; Catherine Butterfield; Ruei-Zeng Lin; Juan M Melero-Martin; Elena Dolmatova; Heather S Duffy; Alexander von Gise; Pingzhu Zhou; Yong Wu Hu; Gang Wang; Bing Zhang; Lianchun Wang; Jennifer L Hall; Marsha A Moses; Francis X McGowan; William T Pu
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

9.  Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling.

Authors:  Bingruo Wu; Zheng Zhang; Wendy Lui; Xiangjian Chen; Yidong Wang; Alyssa A Chamberlain; Ricardo A Moreno-Rodriguez; Roger R Markwald; Brian P O'Rourke; David J Sharp; Deyou Zheng; Jack Lenz; H Scott Baldwin; Ching-Pin Chang; Bin Zhou
Journal:  Cell       Date:  2012-11-21       Impact factor: 41.582

10.  The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression.

Authors:  Kay-Dietrich Wagner; Julien Cherfils-Vicini; Naoki Hosen; Peter Hohenstein; Eric Gilson; Nicholas D Hastie; Jean-François Michiels; Nicole Wagner
Journal:  Nat Commun       Date:  2014-12-16       Impact factor: 14.919

View more
  48 in total

1.  YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.

Authors:  Masum M Mia; Dasan Mary Cibi; Siti Aishah Binte Abdul Ghani; Weihua Song; Nicole Tee; Sujoy Ghosh; Junhao Mao; Eric N Olson; Manvendra K Singh
Journal:  PLoS Biol       Date:  2020-12-02       Impact factor: 8.029

Review 2.  The epicardium as a hub for heart regeneration.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

3.  Targeting NF2-Hippo/Yap signaling pathway for cardioprotection after ischemia/reperfusion injury.

Authors:  Masum M Mia; Ayshwarya L Chelakkot-Govindalayathil; Manvendra K Singh
Journal:  Ann Transl Med       Date:  2016-12

4.  Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice.

Authors:  Anamika Singh; Masum M Mia; Dasan Mary Cibi; Ashutosh Kumar Arya; Sanjay Kumar Bhadada; Manvendra K Singh
Journal:  J Biol Chem       Date:  2019-04-12       Impact factor: 5.157

Review 5.  Hippo-yap signaling in ocular development and disease.

Authors:  Matthew Lee; Navneet Goraya; Seonhee Kim; Seo-Hee Cho
Journal:  Dev Dyn       Date:  2018-04-23       Impact factor: 3.780

6.  Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism.

Authors:  Liangshuai Yuan; Yun Mao; Wei Luo; Weiwei Wu; Hao Xu; Xing Li Wang; Ying H Shen
Journal:  J Biol Chem       Date:  2017-07-11       Impact factor: 5.157

Review 7.  Role of carotenoids and retinoids during heart development.

Authors:  Ioan Ovidiu Sirbu; Aimée Rodica Chiş; Alexander Radu Moise
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-22       Impact factor: 4.698

8.  Alterations in retinoic acid signaling affect the development of the mouse coronary vasculature.

Authors:  Suya Wang; Weiliang Huang; Hozana A Castillo; Maureen A Kane; José Xavier-Neto; Paul A Trainor; Alexander R Moise
Journal:  Dev Dyn       Date:  2018-08       Impact factor: 3.780

9.  Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development.

Authors:  Yang Xiao; Matthew C Hill; Min Zhang; Thomas J Martin; Yuka Morikawa; Suya Wang; Alexander R Moise; Joshua D Wythe; James F Martin
Journal:  Dev Cell       Date:  2018-04-23       Impact factor: 12.270

10.  Retinoic acid signaling promotes the cytoskeletal rearrangement of embryonic epicardial cells.

Authors:  Suya Wang; Jianshi Yu; Jace W Jones; Keely Pierzchalski; Maureen A Kane; Paul A Trainor; José Xavier-Neto; Alexander R Moise
Journal:  FASEB J       Date:  2018-02-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.